Published in Lab Law Weekly, December 15th, 2006
Under the patent, assigned to Aethlon Medical by London Health Science Center Research, Inc., the Aethlon Hemopurifier would address a significant unmet clinical need in cancer therapy by reducing the presence of tumor-secreted microvesicles that inhibit the immune system from responding in cancer patients.
Microvesicular particles are small enough to be separated from circulation by the Hemopurifier,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly